Induction of Survivin Expression by Taxol (Paclitaxel) Is an Early Event, Which Is Independent of Taxol-mediated G2/M Arrest
Xiang Ling(Roswell Park Comprehensive Cancer Center), Fengzhi Li(Roswell Park Comprehensive Cancer Center)
Cited by 175
Related Papers
An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer
|Journal of Experimental & Clinical Cancer Research|2018|67